Skip to main content
NEUROPHET Inc. logo

NEUROPHET Inc. — Investor Relations & Filings

Ticker · 380550 ISIN · KR7380550004 KO Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 41 across all filing types
Latest filing 2025-07-31 Director's Dealing
Country KR South Korea
Listing KO 380550

About NEUROPHET Inc.

http://www.neurophet.com/en

NEUROPHET Inc. is a medical artificial intelligence company that develops solutions for brain disorders. The company specializes in AI-driven brain imaging analysis software designed to support the entire lifecycle of brain disease management, from diagnosis and treatment planning to drug efficacy monitoring and clinical research. Its core technologies are applied across various neurological fields, including neurodegenerative diseases like Alzheimer's, neurovascular conditions, and neuromodulation therapies. By leveraging advanced neuroscience and AI, Neurophet aims to provide accurate and consistent analytical results to medical professionals and researchers to aid in the treatment of brain diseases.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). This is a standard regulatory filing in South Korea (DART system) used by insiders (directors, executives, and major shareholders) to disclose their shareholdings. This falls under the category of 'Director's Dealing' (DIRS) as it reports the ownership status and changes in holdings by a company executive (Bin Jun-gil).
2025-07-31 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report on Large Shareholding' (주식등의 대량보유상황보고서), which is a standard regulatory filing in South Korea (often referred to as a 5% rule filing). It details the acquisition and disposal of shares by Kolon Investment in Neurofit Co., Ltd. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema, as it tracks changes in significant ownership levels.
2025-07-31 Korean
증권발행실적보고서
Share Issue/Capital Change Classification · 100% confidence The document is a '증권발행실적보고서' (Report on the Results of Securities Issuance) filed with the Financial Supervisory Service (FSS) in South Korea. This document provides the final results of a public offering, including subscription details, allocation status, and the use of proceeds. It is a standard regulatory filing required after a capital raise (IPO or follow-on offering). Since it is a formal report of the issuance results rather than a simple announcement of a report, it falls under the 'Regulatory Filings' category as a specific type of post-offering disclosure.
2025-07-18 Korean
[기재정정]투자설명서
Capital/Financing Update Classification · 98% confidence The document is a 'Correction Report' (정정신고서) for an 'Investment Prospectus' (투자설명서) filed by NeuroPhet Co., Ltd. It details amendments to the public offering price, total offering amount, and allocation ratios for a KOSDAQ listing. In the context of financial filings, a prospectus and its subsequent amendments are categorized under 'Regulatory Filings' as they represent the formal registration of securities for public offering, which does not fit into the other specific categories like Earnings Release or Annual Report.
2025-07-14 Korean
[발행조건확정]증권신고서(지분증권)
Share Issue/Capital Change Classification · 98% confidence The document is a '증권신고서(지분증권) 정정신고서' (Securities Registration Statement - Amendment) filed with the Financial Services Commission (금융위원회) in South Korea. It details the finalization of the offering price (공모가액 확정) for Neurophet Co., Ltd. (뉴로핏 주식회사) regarding a public offering of common shares. This document is a formal regulatory filing required for IPOs or capital increases, specifically detailing the pricing, allocation, and underwriting terms. It does not fit into the 'Report Publication Announcement' category because it is the primary regulatory document itself, not a notice of one. Therefore, it is classified as a Regulatory Filing.
2025-07-14 Korean
투자설명서
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a '투자설명서' (Investment Prospectus) for Neurofit Co., Ltd., detailing a public offering of 2,000,000 shares. It includes key information such as the offering price range, subscription period, payment date, and detailed risk factors (business, regulatory, and technical risks). This is a formal regulatory document filed for a securities offering, which falls under the category of a Prospectus/Registration Statement.
2025-07-09 Korean

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.